Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shanjinlian Soft Capsules
- Development stage
- Phase 3
- Lead developer
- Huanghe Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Shanjinlian Soft Capsules (also known as Sanjinlian Soft Capsules or 山金连软胶囊) is a traditional Chinese medicine (TCM) formulation developed by Shanxi Huanghe Chinese Medicine and the Shanxi Huanghe Traditional Chinese Medicine Research Institute. It is formulated as a soft capsule and is being developed for the treatment of the common cold, specifically diagnosed as the wind-heat syndrome in traditional Chinese medicine. The drug is currently in Phase III clinical development in China.
- Other names
- Sanjinlian Soft Capsules山金连软胶囊山金莲软胶囊
Beyond the preview
Go deeper on Shanjinlian Soft Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanjinlian Soft Capsules.